Patent details

EP2594551 Title: Uses of pharmaceutical-grade ferric organic compounds

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
13/03/2025
Unitary Effect Status:
Unitary Effect Request Rejected
Request Unitary Effect Accepted:
Unitary Effect Date:
Unitary Effect Registration Date:
Request Unitary Effect Rejected:
19/05/2025
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been rejected
UPP register:
EP2594551
SPC Number:
Creation Date:

Basic Information

Publication number:
EP2594551
WO Application Number:
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12192822.0
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Taiwan, Chinese Taipei (TW)
Publications:

Dates

Filing date:
18/08/2006
Grant date:
19/02/2025
EP Publication Date:
22/05/2013
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
19/02/2025
EP B1 Publication Date:
19/02/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/08/2026
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
19/02/2025
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
19/02/2025
 
 

 

Name:
Panion & BF Biotech Inc.
Address:
16F, No. 3, Yuanqu Street Nangang District,, TAIPEI, Taiwan, Chinese Taipei (TW)

Inventor

1

Name:
Chan, Keith
Address:
Rockville, MD Maryland 20850, United States of America (US)

2

Name:
Town, Winston
Address:
Hong Kong, China (CN)

Priority

1

Priority Patent Number:
709511 P
Priority Date:
19/08/2005
Priority Country:
United States of America (US)

2

Priority Patent Number:
206981
Priority Date:
18/08/2005
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/295; A61K 33/26; C07C 51/42; C07C 51/41; A61P 13/12; A61P 3/00; A61P 3/12; A61P 3/14; A61P 7/00; A61P 9/00; A61P 27/02; A61P 7/08;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
26/25
Publication date:
25/06/2025
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
08/25
Publication date:
19/02/2025
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202525
Publication date:
18/06/2025
Description:
Unitary Effect Request Rejection

2

Issue number:
202516
Publication date:
16/04/2025
Description:
Unitary Effect Request Receipt

3

Issue number:
202508
Publication date:
19/02/2025
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type